Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA)
Clinical trial NCT04851873 · COMPLETED
Trial details
- NCT number
- NCT04851873
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-08
- Primary completion
- 2023-06-13
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.